Get the Stockscreener App
16.72
2.08%
0.34
After Hours:
16.72
Clearpoint Neuro Inc Stock (CLPT) Latest News
ClearPoint Neuro Inc (CLPT) Q4 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus.com
Clearpoint Neuro Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
ClearPoint Neuro (CLPT) Projected to Post Earnings on Wednesday - Defense World
(CLPT) Trading Report - Stock Traders Daily
The Power Shift: How Small Investors Rule ClearPoint Neuro - Elblog.pl
Power to the People: How Individual Investors Are Influencing ClearPoint Neuro - Zaman
While institutions own 33% of ClearPoint Neuro, Inc. (NASDAQ:CLPT), individual investors are its largest shareholders with 59% ownership - Yahoo Finance
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Short Interest Down 22.1% in January - MarketBeat
Solventum (NYSE:SOLV) and ClearPoint Neuro (NASDAQ:CLPT) Head-To-Head Review - Defense World
What Do Wall Street Analysts Think About ClearPoint Neuro Inc (NASDAQ: CLPT) Stock? - Stocks Register
Legato Capital Management LLC Lowers Stock Holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
After Leaping 25% ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Are Not Flying Under The Radar - Simply Wall St
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025 - ACCESS Newswire
ClearPoint Neuro Sets Stage for Crucial 2024 Financial Review: What the Brain Tech Leader Will Reveal - StockTitan
ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula - WICZ
Game-Changing Brain Drug Delivery Device Gets Major EU Regulatory Win - StockTitan
ClearPoint Neuro (NASDAQ:CLPT) Hits New 12-Month HighTime to Buy? - MarketBeat
CLS publishes half-year report JanuaryJune 2024 - Finansavisen
(CLPT) Investment Report - Stock Traders Daily
ClearPoint Neuro (NASDAQ:CLPT) Shares Up 8.5%Time to Buy? - MarketBeat
JPMorgan Chase & Co. Has $110,000 Holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
CLPT Stock Gains on FDA Clearance for Navigation Software Version 3.0 - MSN
B. Riley Boosts ClearPoint Neuro (NASDAQ:CLPT) Price Target to $20.00 - MarketBeat
Stifel maintains Clearpoint Neuro stock Buy rating, $17 target - MSN
B. Riley Raises ClearPoint Neuro (NASDAQ:CLPT) Price Target to $20.00 - Defense World
How to Take Advantage of moves in (CLPT) - Stock Traders Daily
Stifel maintains Clearpoint Neuro stock Buy rating, $17 target By Investing.com - Investing.com UK
ClearPoint Neuro price target raised to $20 from $15 at B. Riley - Yahoo Finance
ClearPoint Neuro, Inc. (CLPT): A Bull Case Theory - Insider Monkey
B. Riley Raises Price Target on ClearPoint Neuro to $20 From $15, Keeps Buy Rating - Marketscreener.com
ClearPoint Neuro gains FDA clearance for software - MSN
ClearPoint Neuro Secures FDA Clearance for Revolutionary CT Navigation Software - StockTitan
Barclays PLC Raises Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Conway Capital Management Inc. Boosts Stock Holdings in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
ClearPoint Neuro (CLPT) Surges 22.5%: Is This an Indication of Further Gains? - MSN
CLPT Stock Touches 52-Week High at $17.49 Amidst Strong Yearly Growth - MSN
Lake Street Capital Issues Positive Forecast for ClearPoint Neuro (NASDAQ:CLPT) Stock Price - Defense World
ClearPoint Neuro (NASDAQ:CLPT) Sets New 12-Month High After Analyst Upgrade - Defense World
Clearpoint Neuro stock target lifted, buy rating on robust performance By Investing.com - Investing.com Canada
ClearPoint Neuro Reports Third Quarter 2024 Results - ACCESS Newswire
ClearPoint Neuro (NASDAQ:CLPT) Reaches New 1-Year High on Analyst Upgrade - MarketBeat
Clearpoint Neuro stock target lifted, buy rating on robust performance - MSN
1.29%
2.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):